Toggle light / dark theme

Aging on Chip: Harnessing the Potential of Microfluidic Technologies in Aging and Rejuvenation Research

Alternative models for studying aging have employed unicellular organisms such as the budding yeast Saccharomyces cerevisiae. Studying replicative aging in yeast has revealed insights into evolutionarily conserved enzymes and pathways regulating aging[ 12-14 ] as well as potential interventions for mitigating its effects.[ 15 ] However, traditional yeast lifespan analysis on agar plates and manual separation cannot track molecular markers and yeast biology differs from humans.[ 16 ]

Animal models, including nematodes, flies, and rodents, play a vital role in aging research due to their shorter lifespans and genetic manipulability, making them useful for mimicking human aging phenotypes.[ 17 ] These models have provided many insights into the fundamental understanding of aging mechanism. However, animal models come with several limitations when applied to human aging and age-related diseases. Key issues include limited generalizability due to species-specific differences in disease manifestation and physiological traits. For example, animal models often exhibit physiological differences, age at different rates, and may not fully replicate human conditions like cardiovascular disease,[ 18 ] immune response,[ 19 ] neurodegenerative diseases,[ 20 ] and drug metabolism.[ 21 ] Furthermore, in vivo models, such as rodents and non-human primates, suffer from limitations such as high costs, low throughput, ethical concerns, and physiological differences compared to humans. The use of shorter lifespan or accelerated aging models, along with the absence of long-term longitudinal data, can further distort the natural aging process and hinder our understanding of aging in humans. Additionally, many animal models rely on inbred strains, which lack genetic diversity and may not fully represent evolutionary complexity.[ 22 ]

In recent years, microfluidics has emerged as a promising tool for studying aging, offering of physiologically relevant 3D environments with high-throughput capabilities that surpass the limitations of traditional 2D cultures and bridge the gap between animal models and human As a multidisciplinary technology, microfluidics processes or manipulates small volumes of fluids (from pico to microliters) within channels measuring 10–1000 µm.[ 23 ] Traditional fabrication methods, such as photolithography and soft lithography, particularly using polydimethylsiloxane (PDMS), remain widely used due to their cost-effectiveness and biocompatibility. However, newer approaches, including 3D printing, injection molding, and laser micromachining, offer greater flexibility for rapid prototyping and the creation of complex architectures. Design considerations are equally critical and are tailored to the specific application, focusing on parameters such as channel geometry, fluid dynamics, material properties, and the integration of on-chip components like valves, sensors, and actuators. A comprehensive overview of the design and fabrication of microphysiological systems is beyond the scope of this review; readers are referred to existing reviews for further detail.[ 24-26 ] Microfluidic devices offer numerous advantages, including reduced resource consumption and costs, shorter culture times, and improved simulation of pathophysiological conditions in 3D cellular systems compared to other model systems (Figure 1).[ 27 ] Therefore, microfluidics platforms have been extensively employed in various domains of life science research, such as developmental biology, disease modeling, drug discovery, and clinical applications,[ 28 ] positioning this technology as a significant avenue in the field of aging research.

Scientists detect light passing through entire human head, opening new doors for brain imaging

For decades, scientists have used near-infrared light to study the brain in a noninvasive way. This optical technique, known as fNIRS (functional near-infrared spectroscopy), measures how light is absorbed by blood in the brain, to infer activity.

Valued for portability and low cost, fNIRS has a major drawback: it can’t see very deep into the brain. Light typically only reaches the outermost layers of the brain, about 4 centimeters deep—enough to study the surface of the brain, but not deeper regions involved in critical functions like memory, emotion, and movement.

This drawback has restricted the ability to study deeper brain regions without expensive and bulky equipment like MRI machines.

Swarm intelligence directs longhorn crazy ants to clear the road ahead for sisters carrying bulky food

Among the tens of thousands of ant species, incredible “intelligent” behaviors like crop culture, animal husbandry, surgery, “piracy,” social distancing, and complex architecture have evolved.

Yet at first sight, the brain of an ant seems hardly capable of such feats: it is about the size of a poppy seed, with only 0.25m to 1m neurons, compared to 86bn for humans.

Now, researchers from Israel and Switzerland have shown how “swarm intelligence” resembling advance planning can nevertheless emerge from the concerted operation of many of these tiny brains. The results are published in Frontiers in Behavioral Neuroscience.

New proposal aims to protect patients with high-risk brain implants

As companies such as Elon Musk’s Neuralink begin human trials of high-risk brain implants, a new proposal calls for a major change in how the U.S. handles injuries caused by the devices.

The article published in Science suggests a “no-fault” compensation program to help harmed by devices like (BCIs)—even when no one is legally at fault.

These devices, which are implanted in the brain to treat serious conditions like epilepsy or paralysis, can offer life-changing benefits. But they also come with serious risks such as seizures, strokes or even death. And when something goes wrong, patients often have no way to get help or compensation.

This 70-year-old doctor is stronger than ever, and here is HOW he achieved his fitness (no, not just through cardio)

Dr. Eric Topol, a 70-year-old cardiologist, challenges conventional aging perceptions by embracing strength training. Abandoning cardio, he discovered that building muscle mass significantly improves health span. His regimen of simple exercises at home led to increased strength, balance, mental focus, and confidence, proving that aging can be a period of renewal, not decline.

Neural maps used to locate rewards may be disrupted in dementia and heightened in addiction

Imagine you’re walking to work when the unspeakable occurs: Your favorite coffee shop—where you stop every day—is closed. You groggily navigate to a newly opened coffee shop a couple blocks away, which, you’re pleased to discover, actually makes quite a good morning brew. Soon, you find yourself looking forward to stopping at the new location instead of the old one.

That switch probably alters more than just your morning routine. Each time you visit that new coffee shop, the experience likely strengthens a neural map marking the positions of rewarding experiences—a map that can guide you back to those experiences even from miles away.

While the existence of a reward map is familiar from previous work, Wu Tsai Neuro researchers working with were surprised to find that the map persists even when mice move many meters away from a treat, and that it updates almost immediately when the of the treat changes.

Stem cell platform aims to recreate brain’s immune system using lab-grown human microglia cells

Microglia are a specialized type of immune cell that accounts for about 10% of all cells within the brain and spinal cord. They function by eliminating infectious microbes, dead cells, and aggregated proteins, as well as soluble antigens that may endanger the brain and, during development, also help shape neural circuits enabling specific brain functions.

When microglia don’t function properly, they can trigger neuroinflammation and fail to clear away damaged cells and harmful protein clumps—such as the neurofibrillary tangles and amyloid plaques seen in Alzheimer’s disease. This contributes to numerous neurodegenerative diseases, including Alzheimer’s, Parkinson’s and Huntington’s disease, as well as amyotrophic lateral sclerosis (ALS), multiple sclerosis, and other disorders. In fact, neuroinflammation can occur even before proteins start to form pathogenic aggregates and, in turn, accelerates protein aggregation.

Researchers and drug developers aiming to better understand and target microglia functions in the brain are challenged by the fact that human microglia can only be obtained through biopsies, and rodents’ microglia differ from their human counterparts in many critical features. This supply issue prompted them to work on methods to create microglia in the culture dish using stem cells as a starting point. However, to date, this process has remained inefficient, and requires weeks to complete at significant costs.